Cardiovascular & Thoracic Surgery News This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Bariatric Surgery in NAFLD Tied to Lower Heart Disease Risk
(MedPage Today) -- Bariatric surgery was associated with a significantly reduced risk of cardiovascular disease (CVD) compared with nonsurgical care in patients with severe obesity and nonalcoholic fatty liver disease (NAFLD), a large retrospective... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 7, 2022 Category: Cardiology Source Type: news

New consequences for bad workplace behaviour coming to Nova Scotia Health
The head of surgery for Nova Scotia Health’s central zone says new consequences for unprofessional behaviour should help prevent issues from escalating and confront conduct that’s plagued the cardiovascular surgery division for more than a decade. (Source: CBC | Health)
Source: CBC | Health - October 7, 2022 Category: Consumer Health News Tags: News/Canada/Nova Scotia Source Type: news

Concurrent LAA Occlusion Loses Its Appeal for LVAD Surgeons
(MedPage Today) -- NATIONAL HARBOR, Md. -- Innovation in left ventricular assist devices (LVADs) has reached the point that routine left atrial appendage (LAA) occlusion has little to offer anymore in the way of reducing strokes, a MOMENTUM 3... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - October 5, 2022 Category: Cardiology Source Type: news

PCI Not (Much) Worse Than CABG for Multivessel Disease Long Term
(MedPage Today) -- BOSTON -- For multivessel coronary artery disease, percutaneous coronary intervention (PCI) pulled even, statistically speaking, with surgery for outcomes after a median of nearly 12 years of follow-up in the Korean BEST trial... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - September 19, 2022 Category: Cardiology Source Type: news

ADAO Asbestos Prevention and Awareness Conference Runs Sept. 16-17
Discussions Offer Opportunities to Learn Saturday will feature an academic conference highlighted by four 90-minute panel discussions that include many of the experts who have gathered for the event. ADAO Saturday Panel Discussions Session I Progress and Challenges from the Frontline, with moderator Dr. Celeste Monforton. Session II Medical Advancements: Diagnosing and Treating Mesothelioma and Other Asbestos-Related Diseases, with moderator Dr. Arthur Frank. Session III Prevention: Legacy Asbestos: What is it? Where is it? What Do I Do? with mo...
Source: Asbestos and Mesothelioma News - September 15, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Asbestos (general) Awareness/Advocacy Source Type: news

New ESC Guidelines for Cutting CV Risk in Noncardiac Surgery New ESC Guidelines for Cutting CV Risk in Noncardiac Surgery
The guidelines, which aim to reduce cardiovascular complications from noncardiac surgery, introduce new concepts and recommendations compared with the previous 2014 document.Medscape Medical News (Source: Medscape Neurology and Neurosurgery Headlines)
Source: Medscape Neurology and Neurosurgery Headlines - September 14, 2022 Category: Neurology Tags: Cardiology News Source Type: news

Kaiser Study Shows Benefits of Mesothelioma Specialty Centers
Patients diagnosed with pleural mesothelioma are better managed and survive longer when treated at an integrated specialty center, according to a study by Kaiser Permanente that compared its own performance before and after making the transition to specialty care. Doctors at the Kaiser Permanente Northern California health care system found a dramatic improvement once more specialized and standardized treatment was established for mesothelioma patients. The Journal of Thoracic Disease published the results of the findings in August. Mesothelioma patients at Kaiser were three times more likely to receive treatment ...
Source: Asbestos and Mesothelioma News - September 13, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Cancer Center Doctors/Specialists Treatment Source Type: news

Biosense Webster Launches the OCTARAY ™ Mapping Catheter with TRUEref™ Technology
IRVINE, CA – September 6, 2022 – Biosense Webster, Inc., part of Johnson & Johnson MedTech[†], today announced the release of the OCTARAY™ Mapping Catheter with TRUEref™ Technology powered by the CARTO™ 3 Version 7 System. The OCTARAY™ Mapping Catheter was developed for the mapping of cardiac arrhythmias, including atrial fibrillation (AFib). The catheter has eight splines with improved electrode spacing options to provide shorter and more efficient mapping times than PENTARAYTM NAV ECO Mapping Catheter, which may shorten overall ablation procedure times.[2],[8],[‡] AFib is the most common type of cardi...
Source: Johnson and Johnson - September 6, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Study: ‘ Drug-Factory ’ Technology Kills Mesothelioma Tumor Cells in Mice
Tiny, drug-producing beads implanted in the chest cavity could one day provide a powerful platform that would change the way mesothelioma cancer is treated. In a recent study, researchers from Rice University and the Baylor College of Medicine demonstrated the implants’ impressive effectiveness in mice, raising hopes of a possible breakthrough for this tough-to-treat cancer. Researchers have already met with the U.S. Food and Drug Administration, and hope to open a clinical trial to begin testing the procedure’s effectiveness on mesothelioma patients by the second half of 2023. Clinical Cancer Research publis...
Source: Asbestos and Mesothelioma News - August 30, 2022 Category: Environmental Health Authors: Fran Mannino Tags: Clinical Trials/Research/Emerging Treatments Source Type: news

Nonselective Beta-Blockers May Improve Outcomes in Ovarian Cancer
(MedPage Today) -- Women with cardiovascular conditions (CVCs) and ovarian cancer had better 2-year survival if they received a nonselective beta blocker (NSBB) at or around the time of cancer surgery, a review of medical records showed. Two-year... (Source: MedPage Today Hematology/Oncology)
Source: MedPage Today Hematology/Oncology - August 30, 2022 Category: Hematology Source Type: news

High Blood Pressure and Diabetes Are Linked. Here ’ s How to Reduce Your Risk for Both
High blood pressure—also known as hypertension—and Type 2 diabetes are two of the most common medical conditions in the U.S. Unfortunately, they often occur together. Some research has found that 85% of middle-aged or older adults who have Type 2 diabetes also have hypertension, and both conditions elevate a person’s risk for heart disease, stroke, and kidney disease. These increased risks are significant, and in some cases grave. Researchers have found that people with Type 2 diabetes are up to four times more likely to develop cardiovascular disease than those who don’t have the conditio...
Source: TIME: Health - August 29, 2022 Category: Consumer Health News Authors: Markham Heid Tags: Uncategorized Disease freelance healthscienceclimate Source Type: news

U.S. FDA Approves IMBRUVICA ® (ibrutinib) as First and Only BTKi Treatment for Pediatric Patients with Chronic Graft-Versus-Host Disease
August 24, 2022 (HORSHAM, PA) – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that the U.S. Food and Drug Administration (FDA) has approved IMBRUVICA® (ibrutinib) for the treatment of pediatric patients one year and older with chronic graft-versus-host disease (cGVHD) after failure of one or more lines of systemic therapy. This milestone marks the first pediatric indication for IMBRUVICA® and the introduction of a new oral suspension formulation for patients ages one to less than 12. IMBRUVICA® is now the first FDA-approved therapy for these younger patients who previously had no approv...
Source: Johnson and Johnson - August 24, 2022 Category: Pharmaceuticals Tags: Innovation Source Type: news

Potent DAPT After CABG Halves Vein Graft Failure
(MedPage Today) -- Doubling up on antiplatelet agents after coronary artery bypass graft (CABG) surgery cut down on graft failure but increased bleeding risk at least as much, pooled clinical trial data showed. Saphenous vein graft failure risk... (Source: MedPage Today Cardiovascular)
Source: MedPage Today Cardiovascular - August 9, 2022 Category: Cardiology Source Type: news

What Causes Kyphosis?
Discussion There are 3 planes to view and describe spinal deformities from: Coronal or frontal plane – the view is from front or back of the patient Sagittal plane – is the view from the side of the patient Transverse or horizontal plane – is the view from the top or bottom of the patient Normally the spine is straight when viewed from the frontal or coronal plane. Normally the spine also has a small kyphosis in the thoracic region (20-45%) and lordosis in the sacral region when viewed laterally in the sagittal plane. Scoliosis or abnormal deviation of the spinal laterally is the most common spinal defo...
Source: PediatricEducation.org - August 8, 2022 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

CBD Could Help Cops Get Relief From Stress, Insomnia, and Chronic Pain. But Using It Puts Their Job in Jeopardy
There were moments in the past few years when Police Sgt. Brian Vaughan would have tried almost anything to break the cycle of sleeplessness that wore him down—to wash away the images, sounds, and smells of violence that stuck to his memory, and ease the constant pain that was shooting through his back. At one point, he found himself tempted to try CBD, a widely available cannabis derivative that can offer relief from many ailments. “It would have been great to be able to take it and see if it helps,” says Vaughan, a 14-year law enforcement veteran and training coordinator for the police department in Dal...
Source: TIME: Health - July 29, 2022 Category: Consumer Health News Authors: Katja Ridderbusch Tags: Uncategorized Drugs freelance healthscienceclimate Source Type: news